Semaglutide Therapy for Alcohol Reduction - Tulsa

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 7, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions

Alcohol Use Disorder

Interventions

DRUG

Semaglutide

Semaglutide pen injector

DRUG

Placebo

Saline solution

Trial Locations (1)

RECRUITING

OSU Biomedical Imaging Center, Tulsa

All Listed Sponsors

collaborator

National Institute of Drug Abuse

FED

lead

Oklahoma State University Center for Health Sciences

OTHER